{"id":32,"date":"2017-09-12T14:37:44","date_gmt":"2017-09-12T18:37:44","guid":{"rendered":"https:\/\/sites.bu.edu\/gouonevanslab\/?page_id=32"},"modified":"2025-05-20T21:45:34","modified_gmt":"2025-05-21T01:45:34","slug":"32-2","status":"publish","type":"page","link":"https:\/\/sites.bu.edu\/gouonevanslab\/32-2\/","title":{"rendered":"Highlighted Publications"},"content":{"rendered":"

\"\"<\/p>\n

Rizvi, F., Everton, E., Smith, A.R., Liu, H., Osota, E., Beattie, M., Tam, Y., Pardi, N., Weissman, D., <\/span>Gouon-Evans, V<\/strong>. <\/i>(2021).\u00a0Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA.\u00a0<\/span>Nature Communication<\/span>s<\/i>\u00a0<\/span>12, 613. https:\/\/pubmed.ncbi.nlm.nih.gov\/33504774\/<\/a><\/span><\/p>\n

 <\/p>\n

 <\/p>\n

\"\"<\/a><\/span><\/p>\n

Everton, E., Rizvi, F., Smith,. A.R., Beattie, M., Tam, Y., Pardi, N., Weissman, D., Gouon-Evans, V.<\/strong>\u00a0 (2021). Transient yet Robust Expression of Proteins in the Mouse Liver via Intravenous Injection of Lipid Nanoparticle-encapsulated Nucleoside-modified mRNA. Bio Protocol. 2021 Oct 05; 11(19):e4184. PMID: 34722830. https:\/\/pubmed.ncbi.nlm.nih.gov\/34722830\/<\/a><\/span><\/p>\n

<\/h2>\n

Publications Continued:<\/strong><\/h2>\n
    \n
  1. Kim M, Rizvi F, Shin D, Gouon-Evans V. <\/strong>(2023). Update on Hepatobiliary Plasticity. Semin Liver Dis. 2023 Feb 10. doi: 10.1055\/s-0042-1760306. Epub ahead of print. PMID: 36764306. https:\/\/pubmed.ncbi.nlm.nih.gov\/36764306\/<\/a><\/span><\/li>\n
  2. Gouon-Evans V.<\/strong>, and R. Fiorotto. (2022). Fibroblasts to hepatocytes: A nonstop flight into cell therapy for liver diseases?<\/span>Hepatology, Editorial. ; 00:1-3. DOI: 10.1002\/hep.32725. https:\/\/pubmed.ncbi.nlm.nih.gov\/35957526\/<\/a><\/span><\/li>\n
  3. Smith, A.R., Gouon-Evans, V.\u00a0<\/strong> (2022). c-Maf: The magic wand that turns on LSEC fate. Cell Stem Cell. 2022 Apr 07; 29(4):491-493. PMID: 35395181. https:\/\/pubmed.ncbi.nlm.nih.gov\/35395181\/<\/a><\/span><\/li>\n
  4. The liver: A \u201cBlob\u201d that runs the body\u201d, June 12, 2017. New York Times Science.<\/span> https:\/\/mobile.nytimes.com\/2017\/06\/12\/health\/liver-bodily-function.html<\/a><\/li>\n
  5. Goldman O, and Gouon-Evans, V<\/strong>. (2016). Human pluripotent stem cells: myths and future realities for liver cell therapy. Cell Stem Cell<\/u>, Forum, June 2;18(6):703-6. https:\/\/pubmed.ncbi.nlm.nih.gov\/27257759\/<\/a><\/li>\n
  6. Goldman O, Cohen I, and Gouon-Evans V<\/strong>. (2016). Functional blood progenitor markers in developing human liver progenitors. Stem Cell Reports<\/u>, 9;7(2):158-66. PMID: 27509132. https:\/\/pubmed.ncbi.nlm.nih.gov\/27509132\/<\/a><\/li>\n
  7. Goldman, O., Valdes, V.J., Ezhkova, E. and Gouon-Evans, V<\/strong>. The mesenchymal transcription factor SNAI-1 instructs human liver specification. Stem Cell Research<\/u>, 2016, Jul;17(1):62-8. https:\/\/pubmed.ncbi.nlm.nih.gov\/27240252\/<\/a><\/li>\n
  8. Gordillo, M., Evans, T. and Gouon-Evans, V. <\/strong>(2015). Orchestrating liver development. Development<\/u>,142, 2094-2108. https:\/\/pubmed.ncbi.nlm.nih.gov\/26081571\/<\/a><\/li>\n
  9. Goldman, O.*, S. Han*, W. Hamou, V. Jodon de Villeroche, G. Uzan, H. Lickert, Gouon-Evans, V. <\/strong>(2014). Endoderm generates endothelial cells during liver development. Stem Cell Reports<\/u>, 3, 556-565. https:\/\/pubmed.ncbi.nlm.nih.gov\/25358784\/<\/a>\n